Liver Disease Chronic Clinical Trial
Official title:
Research Based on Gut Microbiota Metagenomics for Prevention of Chronic Liver Disease
Gut microbiota modulation has effect on chronic liver disease
Chronic liver disease has been known as a disease of the liver which lasts over a period of
6-month. It consists of inflammation, hepatitis, cirrhosis, hepatocellular carcinoma.
Gut microbiota plays an important roles in the chronic liver disease. It can suppress the
progression of the liver disease by moulation gut microbiota.
The investigators are still evaluating the effect of gut microbiota on the liver disease.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05998330 -
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
|
N/A | |
| Completed |
NCT03459521 -
Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.
|
N/A | |
| Completed |
NCT05729269 -
Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
|
||
| Not yet recruiting |
NCT05205954 -
HepHospital: A Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
|
N/A | |
| Completed |
NCT03130608 -
Inspiratory Muscle Training Post-Liver Transplant
|
N/A | |
| Recruiting |
NCT06111859 -
Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification
|
N/A | |
| Not yet recruiting |
NCT05193201 -
A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
|
Phase 1 | |
| Not yet recruiting |
NCT05062967 -
Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease
|
||
| Not yet recruiting |
NCT05956015 -
Albumin Catabolic Rate Measured by a Stable Isotope
|
N/A | |
| Recruiting |
NCT05017805 -
COVID-19 Vaccines in Patients With Chronic Liver Disease
|
N/A |